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1. Introduction 
1.1. General considerations 
Cardiac myxoma is a benign primitive tumor of endocardial origin that occurs with an 
incidence of 40-50% of all detected primary cardiac neoplasms. The vast majority of them 
are manifest as cavitary gelatinous masses and they may have a smooth or rough surface or 
thrombus adherent. The tumor is constituted by primitive connective tissue cells form rings, 
cords and nests that are often associated with capillaries and they exist in a myxoid stroma 
that is composed of variable amounts of proteoglycans, elastin and collagen. 
Approximately 90% are solitary and pedunculated and the most common site of attachment 
is at the border of the fossa ovalis in the left atrium (75-85%), although myxomas can also 
originate from the atrial appendage, 25% of cases are found in the right atrium and up to 7% 
arise in the ventricular cavities [1]. 
The etiology remains to be determined and most cases are sporadic. About 75% of sporadic 
myxomas occur in females and the mean age for these cases is 55 years. Myxomas are 
familial in only 5-7% of the cases, and they have atypical features such as multicentricity, 
atypical localization, recurrence after excision and association with Carney complex [2]. 
Although atrial myxomas are typically benign, local recurrence due to malignant change has 
also been reported [3]. 
The growth rate of these tumors has been cited as reaching 0.15 cm per month and the 
clinical presentation varies according to the size, tumor's location and mobility (depending 
on the extent of attachment to the interatrial septum) [4-5]. Left atrial myxomas may produce 
symptoms by mechanical interference of blood flow across the mitral valve or pulmonary 
venous drainage, symptoms associated with embolization, constitutional symptoms and 
arrhythmias. Embolism is a major feature of cardiac myxomas, with systemic embolism 
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occurring in 30% to 40% of patients with a left atrial tumor, although in general terms, the 
site is dependent upon the location (left or right atrium). Signs of heart failure with 
pulmonary congestion or pulmonary embolism are presented in 22% and 20% of patients 
respectively, indicating a high-risk situation [6]. Sudden death may occur in 15% patients 
with atrial myxomas and it is typically caused by coronary embolization or obstruction of 
heart valves. 
In about 20% of cases, myxoma may be asymptomatic and discovered as an incidental 
finding by imaging techniques, such as transthoracic or transesophageal echocardiography 
(TEE), cardiac magnetic resonance imaging or computed tomography (CT). Cardiac imaging 
along with a high index of suspicion plays an important role in the diagnosis and 
subsequent management of patients with cardiac myxomas who can potentially benefit 
from surgical treatment. 
Although these tumors are histologically benign, they may be lethal because of their 
strategic position and, after the diagnosis has been established, surgery should be 
performed promptly because of the possibility of embolic complications or sudden death 
previously described. In the past, cardiac myxoma has been generally considered a surgical 
emergency. However, currently it tends to be observed in a more elderly and higher risk 
population, often at an early stage because of the development of cardiac imaging 
techniques and, because of this reason, emergency surgery is not appropriate in stable forms 
[6]. With the exception of real emergency situations, there is no reason why surgery for 
cardiac myxoma should not comply with the usual recommendations for preoperative 
routine assessment before any form of cardiac surgery. 
Long-term follow-up is recommended and annual echocardiograms are useful for early 
detection of recurrent tumors after surgery. 
1.2. Surgical considerations 
Operative resection of atrial myxoma is the treatment of choice and it is a safe procedure, 
with an early postoperative mortality of 2% and an excellent long-term prognosis [7]. 
Surgery is usually curative and includes a complete resection with adequate margin. In most 
cases, cardiac myxomas can be removed easily because they are pedunculated. Simple 
resection is justified in the most of patients, avoiding a large resection of the atrial septum 
below the tumor implantation, although extensive resection appears to be mainly justified in 
high-risk cases of recurrence, such as familial myxomas [8]. Right atrial tumors are resected 
through the right atrium and left atrial tumors can be removed using a trans-septal or trans-
atrial approach. 
Optimal operative technique emphasizes minimal manipulation of the tumor before 
institution of cardiopulmonary bypass (CPB) to prevent fragmentation and embolization 
and the tumor must be removed intact. Recurrence is possible after surgery and it can be 
attributed to incomplete excision of the tumor, intracardiac implantation from the primary 
tumor or growth of a second focus. 
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Traditionally, surgery for cardiac myxomas has been performed by median sternotomy, 
which provides a generous exposure. However, a challenge is occurring and minimally 
invasive cardiac surgery has grown in last decade because of the observed benefits of 
minimal access surgery, such as reduced surgical trauma and decreased pain. Moreover, the 
advancements in three-dimensional (3D) video and robotic instrumentation have 
progressed to a point where a large number of cardiac procedures (including myxomas 
excision) are feasible by specially trained cardiac surgeons. 
Currently, resection of atrial myxomas can be performed through small port sites with 
enhanced technological assistance rather than a traditional median sternotomy. The 
application of robotic telemanipulation systems enables the surgeon to provide the most 
effective and least invasive treatment option available for this condition, offering all the 
potential benefits of a minimally invasive procedure, including smaller incisions with 
minimal scarring, less trauma (including less pain and less bleeding), a decreased risk of 
infection, shorter hospital stay and recovery, and a quicker return to daily activities [9]. 
Removal of left atrial myxomas under robotic assistance has demonstrated to be safe and 
efficient with no limitations to resection of the tumor, allowing the surgeon generous access 
to the heart and surrounding structures. It can be done with reasonable cross clamp and 
perfusion times, conversions to open surgery are uncommon and excellent mid-term results 
can be achieved by well-trained surgical teams. 
With this relatively new technology being more widespread, it is important to know about 
standard surgical procedure for resection of left atrial myxomas under robotic assistance, as 
well as acknowledge any related complications for this procedure. 
2. Historical background 
Prior to advances in robotic technology, a variety of smaller incisions were developed for 
endoscopic heart operations in the mid-1990s, such as coronary artery bypass grafting or 
valve surgery [10-11]. In 1998, Carpentier [12] and Mohr et al [13] performed endoscopic mitral 
procedures and coronary artery bypass grafting using peripheral perfusion and endoaortic 
cross-clamp techniques. 
Minimally invasive approaches have also been applied for cardiac myxomas resection, such 
as right parasternal or partial sternotomy with standard cardioplegic techniques [14], right 
submammary port-access method with antegrade cardioplegia and ascending aortic balloon 
occlusion [15] or right submammary incision with femoro-femoral bypass and nonclamped 
ventricular fibrillation [16]. In general terms, video-assisted resection by using these 
approaches has been successfully described, providing satisfactory exposure for atrial and 
ventricular myxomas [17-19]. 
Nevertheless, endoscopic instrumentation (with four degrees of freedom) reduces the 
dexterity needed for delicate cardiac surgical procedures, along with the loss of depth 
perception by using two-dimensional viewing systems. Robotic technology provides a 
solution to these problems and it has been born to facilitate cardiac procedures, initially by 
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providing enhanced endoscopic camera control and in the recent decade, by allowing the 
manipulation of surgical instruments through thoracoscopic port incisions. 
In 2001, Torracca et al [20] first reported a series of atrial septal defect closure using robotic device 
in Europe and, in the last decade, surgical telemanipulation systems have expanded to coronary 
revascularization, left ventricular lead implantation, congenital heart surgery, valvular surgery, 
arrhythmia procedures (Cox-Maze III) and cardiac tumors. The American Heart Association 
identified robotic surgery as one of the top 10 research advancements of 2002 [21]. 
The first group of robots consisted of assisting tools that were used for holding and 
positioning the endoscope during surgery, such as the robot AESOP (Automatic Endoscopic 
System for Optimal Positioning; Computer Motion Inc, Goleta, CA) [22], although cardiac 
procedures have not obtained any relevant benefit from this system. 
The second group comprises surgical telemanipulation systems, which are under the control 
of a surgeon who works at the console. The development of telemanipulation systems was 
performed in the late 1980s: the da Vinci Surgical System (Intuitive Surgical Inc, Sunnyvale, 
CA) and the ZEUS robotic system (Computer Motion Inc, Goleta, CA) [23]. In 2003, Intuitive 
Surgical and Computer Motion agreed to merge and the ZEUS system was phased out in 
favor of the da Vinci system. 
The advantages of the da Vinci system include 3D-viewing system, the robotic wrist and it 
can provide up four robotic arms. These characteristics seems to be more advantageous in 
mammary artery harvesting for coronary artery bypass grafting, but are also interesting 
features for a number of cardiac procedures, such as atrial myxomas excision. 
The initial experience with robot-assisted excision of left atrial myxomas has been reported 
using the da Vinci Surgical System and it is the most widely used for cardiac procedures. It 
comprises three components: a surgeon’s console, an instrument cart (including two robotic 
operating arms with a diameter of 11 mm, their articulating instruments, the camera arm 
and an optional fourth arm) and a 3D-visioning platform for enabling natural depth 
perception with high-power magnification. The surgeon is seated in front of the computer 
console and operates the robotic arms while viewing the surgical field in 3D-image. The 
finger and wrist movements are registered digitally and the dual master controls translate 
them to the operation being performed on the patient with the surgical robotic arms, 
allowing various types of movements including rotating, sliding and squeezing. “Wrist-
like” instrument articulation emulates the surgeon’s actions at the tissue level, and dexterity 
becomes enhanced through combined tremor suppression and motion scaling. It minimizes 
opportunities for human error when compared with traditional approaches. 
3. Application area 
As mentioned above, robotic-assisted cardiac surgery using the da Vinci Surgical System has 
allowed performing selected coronary artery bypass surgery, mitral valve repair or 
replacement, atrial and ventricular septal defect repairs [24-25] and most recent totally endoscopic 
removal of atrial myxomas. Isolated cases of removal of uncommon cardiac tumors using 
 
Robotic Resection of Left Atrial Myxoma 151 
robotic techniques have also been reported, such as aortic valve papillary fibroelastoma, with 
excellent results [26]. 
The first successful application of robotic technology for totally resection of left atrial 
myxoma with da Vinci Surgical System was reported in 2005 by Murphy and associates [27], 
through transeptal and left atrial approaches. In 2008, at Beijing (China), Changqing Gao et 
al reported a new successful resection of left atrial myxoma by using this technology [28]. To 
date, approximately 30 cases of cardiac myxomas excision under robotic assistance have 
been described [28-29] and this author have reported the largest single institution series of 
robotic resection of left atrial myxomas, with 19 consecutive patients undergoing this 
procedure with no operative deaths or strokes [30] and follow-up echocardiograms up to 18 
months noted no recurrence or atrial septal defect. 
To minimize patient risk in this setting, cardiac surgeons should have previous 
experimental training in robotic techniques (in vivo animal laboratory work and human 
cadavers can be used) and they must demonstrate clinical proficiency to operate the robotic 
equipment per FDA (Food and Drug Association) approved company testing. 
4. Surgical procedure 
4.1. Anesthetic considerations 
Some anesthetic considerations must be done. Cardiac anesthesiologists must be trained in 
order to recognize potential complications and challenges posed by the use of robotic 
systems, such as long surgical times or problems with single-lung ventilation. Management 
of TEE and minimally invasive percutaneous CPB management are also desirable for the 
anesthesiology team. 
Patient monitoring consisted of standard electrocardiography, oxygen saturation, end-tidal 
CO2, bispectral index, urine output and nasopharyngeal and bladder temperatures. Arterial 
blood gas analysis for acid-base status, oxygen and CO2 arterial pressures, hematocrit, 
haemoglobin, potassium and ionized calcium is performed during the procedure as needed. 
TEE is a valuable adjunct in robotic cardiac surgery. During establishment of peripheral 
CPB, TEE is used to guide placement of the cannulas in the inferior and superior venae 
cavae and ascending aorta. When the midesophageal bicaval view (80-110º) is obtained, the 
venous cannula must be identified as two parallel lines surrounding the fluid-filled lumen. 
As example, the midesophageal aortic valve long-axis view (120-160º) can be obtained to 
assess the placement of the endoclamp for aortic occlusion when it is used. 
After weaning from CPB, TEE is also used to evaluate the completeness of air removal. TEE 
identifies patients at risk for significant complications before they leave the operating room [31]. 
Other special anesthetic considerations required for robotic cardiac surgery, in order to 
maintain stable hemodynamic and oxygenation, are single-lung ventilation and carbon 
dioxide insufflation [32]. It may reduce cardiac output and result in hypercapnia and hypoxia. 
These characteristics are especially relevant for patients with chronic obstructive pulmonary 
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disease because of the creation of a transpulmonary shunt through the collapsed lung, 
worsening arterial oxygenation. 
An active communication between anesthesiologist and surgeon is key to ensure the 
success, timely execution and safety of cardiac robotic surgery. 
4.2. Surgical approach 
Robotic resection of left atrial myxomas is considered a good right-sided atrial approach 
with excellent visibility, which includes an adequate exposure of the attachment point of the 
tumor, excision of tissue margins and debridement, meticulous removal without 
fragmentation and a careful examination of intracardiac chambers. To date, robotic 
enhancement has been used to perform portions of intracardiac procedures via thoracotomy 
incisions as well as the application of this technology for totally endoscopic open heart 
surgery. For removal of left atrial myxomas, both approaches have been reported. 
In first place, robotic arm placement and specialized equipment must be reviewed with the 
operating room staff. 
Then, the patient is anesthetized and intubated with a dual-lumen endotracheal tube, 
allowing single left-lung ventilation; the lung needs to be deflated on the side of the chest 
that the robot is entering so visualization of the heart is not obstructed. Arterial pressure 
monitoring line and central venous catheter are inserted and transesophageal 
echocardiographic (TEE) study is performed. If an endoclamp for aortic occlusion is used, 
bilateral radial arterial catheters are required to monitor correctly balloon placement. 
As there is limited access to the heart for direct defibrillation, external defibrillator pads are 
required. 
The patient is positioned with the right chest elevated 30°–45° and the right arm positioned 
along the right side. This position permits direct access to the thoracic cavity and decreases 
the risk for brachial plexophaty. Patient positioning is of fundamental importance in 
decreasing patient-robot conflict during surgery, defined as a limitation in the free 
movement of the robot’s telemanipulated arms by interference with the patient’s body. 
Percutaneous cannula (15-17 F) is inserted through the right internal jugular vein for 
drainage from superior cava vein under TEE assistance (Figure 1).  
After sterile preparation and draping the patient, a transverse right groin incision is made 
and femoral artery and vein are dissected and prepared for cannulation (Figure 2). 
When totally robotic resection of left atrial myxoma is performed [28], the da Vinci endoscope 
is inserted through a 12-15 mm port in the fourth intercostal space (ICS), approximately 2-
cm lateral to the midclavicular line. The camera is then introduced through the endoscope 
port into the pleural space and a small working port (2 cm) is created in the same ICS 
upward from the camera port. 
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Figure 1. Percutaneous cannula through the right internal jugular vein. This venous cannula is 
advanced into the right atrium. 
 
Figure 2. The common femoral artery and femoral vein are dissected free from the surrounding 
structures. Both are dissected circumferentially and vessel-loops are placed for bleeding control. 
Then, the da Vinci instrument arms are inserted in their respective ports through three 1-cm 
trocar incisions in the right side (anterior axillary line): the right instrument arm is 
positioned 5 cm lateral to the working port in the 6th ICS; the left arm, medial and cephalad 
to the right arm in the 2nd or 3rd ICS; and the fourth arm trocar is placed in the 
midclavicular line in the 5th ICS (to achieve an optimal interatrial exposure). For this 
approach, no rib-spreading retractor is necessary. 
In selected cases, this approach can be modified and removal of giant left atrial myxomas is 
performed via thoracotomy incision under robotic assistance (Figure 3).  
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Figure 3. Positioning of the patient when anterolateral thoracotomy under robotic assistance is the 
selected approach.  
 
Figure 4. Anterolateral thoracotomy. The da Vinci endoscope is introduced through the incision. 
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For these cases, a right submammary skin incision (about 9-10 cm) is made with the aim of 
reaching the chest wall, retractor is used and the camera is then introduced (Figure 4). This 
camera port and the working port can be fused together to be a new work-port for the 
intracardiac procedure. 
For both approaches, after port insertion, the entire operation (including pericardiotomy, 
atriotomy and myxoma excision) are performed with robotic assistance. 
After the selected approach has been initiated, the patient is heparinized and peripheral 
cannulation is performed as previously described for minimally invasive cardiac surgery [33] 
(bicaval venous drainage through the jugular and femoral cannulas along with arterial 
perfusion through femoral cannula placed into the ascending aorta). The sizes of the 
cannulas are determined by the patient’s body surface area and circulatory requirements. 
Cannulas are inserted over the Seldinger guidewire, are confirmed to be in the correct 
placement by TEE and the guidewire is then removed. 
After the da Vinci endoscope and instrument arms have been inserted (Figure 5), pleural 
adhesions are rule out, the right pleural space is insufflated with carbon dioxide to create 
working space (intrapleural pressure of 5 to 10 mm Hg) and, via 4 port incisions and a 
working port, this procedure can be completed with a 30° angled endoscope facing upward 
with the da Vinci Surgical System. 
 
 
Figure 5. View of the da Vinci robotic system’s arms positioned in the patient’s chest, for robotic 
assistance when a thoracotomy incision has been made.  
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The operating surgeon is positioned at the operative console and begins the intrathoracic 
portion of the operation by controlling the robotic camera and surgical instrument arms. The 
patient-side assistant changes instruments, supplies and retrieves operative materials. 
The pericardium is opened with direct visualization of the phrenic nerve (3-4 cm anterior to 
the nerve) and it is excised (for a possible atrial septal reconstruction). Traction sutures are 
placed low on the pericardium on the right side (usually three sutures are necessary for 
better visualization of the septal rim of the left atriotomy). This maneuver enables an 
optimal exposure of the left atrium. 
The venae cavae are encircled with linen tapes and caval snares are placed using a long-tip 
forceps and passed out of the working port. Total CPB is started. Usually, CPB is established 
at 26 °C through peripheral vessels, using femoral arterial inflow and kinetic venous 
drainage through a femoral (21–23 Fr) and right internal jugular vein (15-17 Fr) cannula. 
The management of extracorporeal circulation for robotically assisted cardiac surgery has 
suffered modifications from the standard procedures. As mentioned above, for most of the 
patients, extracorporeal circulation is established through a femoral arterial cannula, 
femoral venous cannula and right internal jugular venous cannula, with vacuum-assisted 
venous drainage and continuous blood gas monitoring. The femoral artery needs to be able 
to fit this cannula and provide adequate flow. A learning curve of perfusion technique is 
necessary for the establishment of this type of extracorporeal circulation system and 
adequate communication between the surgical team is essential. 
There are different venous cannulas for peripheral cannulation in robotic surgery, such as 25 
F Quickdraw (Edwards LifeSciences, CA, USA) or 21-23 F cannula (Medtronic, Inc, 
Minneapolis, Minnesota, USA). For arterial cannulation, different cannulas can be used. For 
endoaortic clamp, a 21-23 F EndoReturn cannula (Edwards LifeSciences, Irvine, CA, USA) is 
available. Any standard femoral access cannula may be used if cross-clamping is going to be 
achived. Finally, a remote access perfusion cannula has been developed to avoid both 
retrograde perfusion and cross-clamping (RAP Cannula, Estech Inc., Danville, CA, USA). 
Aortic occlusion can be performed with a transthoracic cross-clamp, such as Chitwood 
(Scanlan International, Minneapolis, Minnesota, USA) developed by Chitwood, Elbeery and 
Moran [34], which enables central aortic occlusion without the use of an intra-aortic balloon. 
It is inserted through the 3rd or 4th ICS in the midaxillary line and is applied across the aorta. 
It is usually used for patients in whom use of endoaortic occlusion balloon is not indicated 
due to extensive calcification or tortuosity of aorto-iliac axis or aneurysmal disease. 
When endoaortic clamping is going to be achieved, the aortic balloon is positioned in the 
ascending aorta (1 cm above the sinotubular junction) by TEE assistance. The aortic balloon 
is then inflated to a pressure of 250 to 300 mm Hg. The myocardium is protected with 
antegrade cold blood cardioplegia delivered through the distal lumen of the balloon, or 
directly through the second ICS working port with a 14 F angiocatheter if cross-clamping is 
used. Then, the heart is arrested. Repeat doses can be given when necessary during the 
procedure. Currently, the cardioplegia cannulas used in this setting are the dual-lumen 
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antegrade cardioplegia cannula (Medtronic DLP, Minneapolis, MN), allowing for the 
simultaneous delivery of cardioplegia and aspiration of the aorta and left heart; or the RAP 
cannula (Estech, Inc, Danville, CA) mentioned above. 
De-airing is ensured through the same angiocatheter for cardioplegia or with a left vent 
across the mitral valve. 
When left atrial myxomas are attached to the interatrial septum, exploration can be achieved 
through an oblique right atriotomy for an optimal exposure of the atrial septum [27] and, when 
the point of attachment has been identified, the incision can be made in the septum (medial to 
the fossa ovalis) and it is extended 360º around the myxoma attachment following the 
entering to the left atrium. For this approach, margins of normal septal tissue must be 
maintained. 
A left atriotomy through Sondergaard’s groove (anterior to the pulmonary veins) has been 
also described for patients with tumor attachment to the posterior left atrial wall. Traction 
sutures can be placed at the left atriotomy and pulled upward, or and atrial retractor 
(Estech, Inc., Danville, CA, USA) can be used for achieving an optimal operative field. 
For selected cases, an atrial EndoWrist retractor (Intuitive Surgical, Inc, CA) is placed 
through the fourth robotic arm for an adequate exploration of the atrial myxoma. This 
dynamic robotic atrial retractor makes the right side of the heart to rotate up and the left 
side to rotate down and, along with the magnification provided by the robotic optical 
system, enhances the exposure and visualization in the left atrium. 
Then, excision can be achieved by dissecting a plane at the point of attachment and atrial 
septum is maintained. Calcified areas and adherences must be identified. When atrial 
myxomas are located in the right atrium, they can be completely resected from the beating 
heart with the superior and inferior venae cavae snared. 
Resection of full-thickness wall or only an endocardial attachment is controversial, although 
a partial thickness resection of the area of tumor attachment when anatomically is necessary 
has been reported, without an increase in recurrence rate [35]. The base of the myxomas can 
also be cauterized to prevent recurrence when, despite to be anatomically necessary, it has 
not been completely resected. 
Because myxomas are generally very friable, their removal through a small working port is 
an important step during the robotic procedure. Endoscopic specimen baskets have been 
developed and are routinely used for laparoscopic procedures with good results and its use 
to catch and remove atrial myxomas has demonstrated to be safe and without risk for the 
patient when a video-assisted myxoma excision is performed [17]. For robotic procedures, the 
tumor is removed and grasped by the tissue margins and is extracted using an Endopouch 
bag (Ethicon Endo-Surgery, Cincinnati, Ohio) through the service port without 
fragmentation in the pleural space. 
A vacuum-extractor device has also been reported for this procedure [36], allowing the 
extraction of giant left atrial myxomas. The components for this device are the top of a 
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plastic bottle of fluid serum (of 3-5 cm in diameter) connected to a flexible tube with a 
suction device. It is introduced and placed without aspiration through a thoracotomy 
incision, facilitated with the robotic magnification, and once the tumor is reached, it is 
removed with vacuum-traction under active aspiration (Figure 6). This device allows the 
manipulation and a complete removal of the tumor, even if it is friable. 
The interatrial septum can be removed with the tumor, but it seems to be indicated only in 
high-risk patients. When an atrial wall defect is created after excision (usually at the 
septum), it is repaired using the principles learned from endoscopic atrial septal defect 
repair. It can be repaired primarily by a running suture in the most of cases or by patch 
closure using autologous or bovine pericardium. After resection, empty left atrial and left 
ventricular chambers inspection is accomplished with the da Vinci endoscope. 
The entire procedure can be performed with the da Vinci Surgical System, including left 
atrial closure with running suture, although the left atrium can be closed under direct vision 
to decrease operative times for selected patients. 
 
Figure 6. Resection of a giant atrial myxoma through a left atrial approach using the da Vinci Surgical 
System. Vacuum-extractor into the left atrium (viewing from the console’s surgeon). 
After de-airing, aortic cross-clamp is deflated and removed. TEE is used for proving the 
absence of tumor in cardiac chambers, adequate removal of air as well as residual atrial 
septal defect or mitral regurgitation (Figure 7). Then, the patient is rewarmed and weaned 
from CPB. 
Protamine is given and the femoral vessels are repaired once off CPB and the groin incision 
is closed. When cardioplegia has been infused through the second ICS, the site can be closed 
with extracorporeal knot tying through the working port and surgical close of the chest wall 
may be performed in the standard fashion. 
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Figure 7. TEE allows for an exhaustive inspection the cardiac chambers after removal of the atrial 
myxoma. 
In most of patients, temporary cardiac pacing wires are not routinely required. When this 
step is required, it must be performed previously to removal of aortic clamp. The chest 
tube (or Blake drain, depending on institution) is placed in an existing intercostals porthole 
and they are usually left in the pericardium and in the right pleural space. The double-
lumen endobronchial tube can be changed to a single-lumen tube. In selected cases, the 
patient can be extubated in the operating room or shortly upon arrival to the intensive care 
unit. 
5. Results 
5.1. Current results 
In general terms, although experience is limited, surgical results at a relatively large number 
of centres worldwide are optimal and this technology is of reproducible value with excellent 
cosmetic results. Despite successful cases reported of robotic-assisted excision of left atrial 
myxomas, most surgeons continue to use a median sternotomy approach. 
An endoscopic approach to left atrial myxomas is appropriate only when the exposure of 
the attachment point of the tumor is optimal, excision of adequate tissue margins, removal 
with no fragmentation, reconstruction of atrial wall defects and an exhaustive inspection the 
cardiac chambers after removal of the atrial myxoma. These surgical tenets are achieved 
with the robotic technology.  
Cross-clamp and perfusion times are longer under robotic assistance compared with 
conventional surgery [37-38], although a longer CPB time has not demonstrated any negative 
impact on operative and postoperative outcomes. 
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Increased total operative and cross-clamp times have been demonstrated for the endoaortic 
balloon versus the transthoracic clamp for valve surgery [39], but there are no studies for left 
atrial myxoma excision.  
Learning curve can be long and minimally invasive surgery experience is desirable. The 
learning curve has demonstrated a progressive decline in cross-clamp, CPB, and overall 
operative times [40]. 
The perioperative results are similar to those obtained using traditional approaches and no 
serious complications during the robotic procedure have been reported in this setting. 
Necessity of conversion to sternotomy due to robotic system malfunction has not been 
described and to date, no operative mortality or neurologic complications have been 
observed [30]. 
The long incision in the midline of the chest, the risk of bleeding and infection and the 
relatively long recovery time after surgery seem to be avoided with robotic cardiac surgery. 
Usually, these patients benefit from low blood transfusion rate. 
Intensive care unit stay duration is reduced in several studies [41-42]. Moreover, the patients 
are usually ready to be discharged on the third or fourth postoperative day and patient 
education regarding to sternotomy precautions is not needed for totally endoscopic cardiac 
surgery. Most patients can return to work in two or three weeks. Excellent quality of life has 
been demonstrated and, after discharge, these patients must be scheduled for a follow-up 
echocardiogram to rule out any recurrence of the myxoma. 
Mid-term follow-up comparative studies between conventional and robotic surgery for 
removal of atrial myxomas are not yet available and data that include mid- and long-term 
follow-up are required. 
5.2. Pitfalls and complications 
It is important to keep in mind the potential complications for robotic extraction of left atrial 
myxomas. The working ports are only 2-2.5 cm in length and, during tumor resection 
through these small incisions, care must be taken to excise the mass entirely, given the 
friability of myxomas. Any fragment dropped during removal creates a high risk of 
systemic embolization and stroke [43]. When a left atrial approach is used, a “non-touch” 
technique (not possible with a conventional biatrial approach) is achieved, decreasing the 
risk for fragmentation of the tumor. 
Vascular injuries from peripheral cannulation include arterial occlusion or aortic dissection 
(although extremely rare, but devastating). 
In general terms, cardiac surgeons must be prepared to convert to a lateral thoracotomy or 
full sternotomy in case of unsuccessful result or emergency during the robotic procedure. 
For this reason, they must plan the alternative surgical procedure and choose the optimal 
access in advance.  
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5.3. Limitations 
The early clinical experience with computer-enhanced telemanipulation systems has defined 
many of the limitations of this approach despite rapid procedural success. Limitations can 
include an incomplete and delayed motion tracking, although this limitation might 
negatively affect the quality of an anastomosis in beating-heart surgery, such as coronary 
artery bypass grafting [44], and it does not seem relevant for intra-cardiac tumor resection. 
Lack of tactile feedback has demonstrated to be also a limitation: the visual force feedback 
primarily benefits inexperienced robot-assisted surgeons, with diminishing benefits among 
experienced surgeons [45]. 
The operation is demanding, expensive and it is only suitable for a selected patient 
population, but elevated costs of instruments and maintenance may be justified by a speed 
of recovery and reduction in hospital stay [46]. It is necessary to determine the cost of these 
systems by virtue of their measured benefits. 
Longer operative times and learning curve, above mentioned, are due to the complexity of 
the system and because of this reason, this technology must be concentrated in a few 
reference centres with a high volume and expertise cardiac surgeons. 
6. Further research 
To date, literature about feasibility of robotic resection of left atrial myxomas is focused on 
small series or isolated case reports, and the world experience is mostly retrospective and 
noncontrolled. 
There are no randomized studies comparing robotic to either video-assisted or sternotomy or 
thoracotomy left atrial myxoma excision and, although it is generally believed that patient 
morbidity is significantly reduced with this minimally invasive approach, further studies are 
needed to support this hypothesis. Despite early procedural success, future refinements in 
these devices such as "haptic" technology, which provide tactile and resistance feedback to the 
surgeon, are needed to apply this new technology more widely in this era of cardiac surgery. 
The results of robotic procedures should be at least equivalent to those of conventional 
methods and the time required should be comparable to conventional surgery. Long-term 
results are needed to determine whether robotic technology could become a new standard 
in cardiac tumors excision. 
7. Conclusion 
Computer-aided robotic surgical technology is a safe procedure and can be used to perform 
open-heart procedures such as atrial myxomas excision with a totally endoscopic approach. 
Atrial myxoma resection using surgical telemanipulation systems such as the da Vinci 
Surgical System have achieved excellent results and provide an attractive cosmetic 
advantage over traditional approaches. 
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Adults with atrial myxomas are a small but constant and growing population of patients 
who can benefit of this minimally invasive approach. 
Decreased postoperative pain and recovery times along with improved cosmetic results are 
the main benefits for this approach. 
Further research is necessary to demonstrate the reproducible value for this technology in 
patients with cardiac tumors on a larger scale. 
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